Advancing Health with Oligo Fucoidan: Features, Research, and Applications #
OliFuco® is a low molecular weight fucoidan powder, carefully extracted from naturally dried, oceanic brown seaweed (Saccharina Japonica). Developed as a dietary health ingredient, it is standardized through freeze-drying and hydrolysis extraction, ensuring high purity and concentration. Its efficacy and safety are supported by scientific studies and human clinical trials, making it a versatile option for health and wellness formulations.
Key Features #
- Low Molecular Weight Fucoidan Powder (molecular size < 1500Da)
- High Purity and Concentration via hydrolysis extraction
- Standardized Freeze-Dried Brown Seaweed Polysaccharide Extract
- Supported by Human Clinical Trials and Scientific Data
- Awarded the Taipei Biotechnology Award
- Over 50 International Scientific Publications
- Halal Certified
Scientific Evidence and Health Benefits #
OliFuco® has been the subject of extensive research, with more than 50 scientific papers published on its bioactivity and health benefits. The research and development team at Hi-Q collaborates with leading scientists and medical professionals to advance the understanding of Oligo Fucoidan.
Bi-Directional Immunomodulatory Effects #
OliFuco® is a bioactive polysaccharide known for its unique bi-directional immunomodulatory properties. It can both stimulate and suppress immune responses, depending on the context:
- Immune Stimulation: Supports immune cell activity, beneficial for fighting infections or as an adjunct in cancer immunotherapy.
- Anti-Inflammatory Action: Helps alleviate chronic and systemic inflammation.
Potential Health Applications #
- Cancer Care
- Immune Health
- Inflammation Care
- Liver, kidney, and heart health support
Clinical Research Highlights #
Hi-Q has invested in the development of Oligo Fucoidan as an adjunct supplement for cancer patients, aiming to relieve side effects such as cachexia. Collaborative research with Kaohsiung Medical University Hospital (Taiwan) led to a double-blind, randomized, placebo-controlled clinical trial in metastatic colorectal cancer (mCRC) patients. The study demonstrated that Oligo Fucoidan, when combined with chemotarget agents, significantly improved the Disease Control Rate (DCR), reaching up to 92.8%.
- Study Design: Prospective, randomized, double-blind, controlled trial
- Outcome: Enhanced disease control in metastatic colorectal cancer patients
- Significance: Supports the use of natural fucoidan as a supplemental therapy alongside conventional cancer treatments
Product Specifications #
- Botanical Origin: Saccharina Japonica (Laminaria Japonica)
- Molecular Size: < 1500Da
- Appearance: Light brown powder
- Flavor: No odor, slight seaweed taste
- Claims: Immune modulation, adjuvant functional support for medical purposes
- Applications: Suitable for capsules, tablets, powder sachets, and a variety of health supplement, functional food, and nutritional formulations
For further details or collaboration inquiries, contact Hi-Q.